TechnipFMC plc Ordinary Share vs Novavax Inc — how do they compare? TechnipFMC plc Ordinary Share trades at $69.99 (market cap $27.31B), while Novavax Inc trades at $11.1 (market cap $1.82B). The key difference: TechnipFMC plc Ordinary Share is far larger — about 15× Novavax Inc's market cap, and TechnipFMC plc Ordinary Share pays a 0.29% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold TechnipFMC plc Ordinary Share for 0 Days and Novavax Inc for 59 Days on average.
| FTI | NVAX | |
|---|---|---|
Market Cap | $27.31B | $1.82B |
Volume | 2,496,410 | 6,198,505 |
Sector | Energy | Health |
52-Week High | $80.08 | $12.56 |
52-Week Low | $35.57 | $6.22 |
Typical Hold Time | 0 Days | 59 Days |
Enterprise Value | $27.56B | $1.39B |
Dividend Yield | 0.29% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Novavax (NVAX) trades at $11.22, down 0.88% on the day, with a bullish technical signal from moving averages and strong analyst support (74% buy ratings). The company shows mixed fundamentals with a positive P/E of 3.14 and EV/EBITDA of 1.72, but negative net income margin of -59.87% and negative shareholder equity. Recent developments include regulatory approvals for its updated COVID-19 vaccine and strategic pivot toward Matrix-M adjuvant licensing partnerships.
The outlook remains speculative with significant execution risks in the transition from COVID vaccine dependency to partnership-driven model. While valuation metrics appear attractive and technical momentum is positive, persistent negative cash flows and competitive pressures in the biotech sector warrant caution. The stock presents high-risk, high-reward potential for investors comfortable with biotech volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
TechnipFMC is an energy technology company providing subsea systems, surface technologies, and related services across the life of oil and gas fields. Its offerings include equipment, controls, installation support, and digital tools for offshore and onshore projects.
Read more on FTI →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →